C4 Therapeutics Inc.
CCCC
|
|
| |
|
| Trading Volume | 96,141 |
|
|
11.00 - 1.18 |
| Market Cap Full | $ 315.5M |
Quarterly +
| 2026 | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
| Q1 | -33% | 8.7% | 44.6% | -46.8% |
| Q2 | - | 32.9% | -43.2% | -12.4% |
| Q3 | - | 32.9% | -4.2% | -32.4% |
| Q4 | - | 32.9% | -40.4% | 232.4% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2026 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - |
| 2025 | |||||||||||
| 8.7 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| 9.4 | 77.7 | -25.6 | -17.4 | -25.9 | -7.8 | 45.6 | -4.2 | - | - | - | -21.6 |
| 2023 | |||||||||||
| 32 | -32.4 | -40.4 | -3.8 | 12.3 | -18.9 | 41.5 | -25.5 | -35.9 | -19.9 | 9.4 | 246.6 |
| 2022 | |||||||||||
| -27.3 | -8.2 | 8.2 | -64.7 | -15.3 | 3.9 | 27.9 | 4.6 | -13 | 9.7 | -10.9 | -31.2 |
| 2021 | |||||||||||
| 2.9 | 19.8 | -13.8 | -11.4 | 12.7 | 2.4 | 15.3 | -8 | 11.5 | -0.7 | -18.7 | -6.9 |
EPS
| 2023 | 2022 | 2021 | |
|---|---|---|---|
| Q1 | -0.7 | -0.7 | -0.5 |
| Q2 | -0.7 | -0.6 | -0.5 |
| Q3 | -0.6 | -0.7 | -0.5 |
| Q4 | 0 | -0.8 | -0.3 |
| A | -1.99 | -2.6 | -1.8 |